AdultPediatricFibrodysplasia Ossificans Progressiva Pending FDA approval for prevention of for prevention of heterotopic ossification (ie, new bone formation outside of the normal skeletal system) associated with fibrodysplasia ossificans progressiva (FOP)Fibrodysplasia Ossificans Progressiva Pending FDA approval for prevention of for prevention of heterotopic ossification (ie, new bone formation outside of the normal skeletal system) associated with fibrodysplasia ossificans progressiva (FOP) in females aged ≥8 years or males ≥10 years Mechanism of Action Selective retinoic-acid receptor gamma (RARγ) agonist for prevention of heterotopic ossification (ie, new bone formation outside of the normal skeletal system) associated with fibrodysplasia ossificans progressiva No images available for this drug. No images available for this drug.A Patient Handout is not currently available for this monograph.Print